Singular Genomics Systems Inc (NAS:OMIC)
$ 0.33905 -0.00375 (-1.09%) Market Cap: 25.12 Mil Enterprise Value: -51.80 Mil PE Ratio: 0 PB Ratio: 0.16 GF Score: 32/100

Singular Genomics Systems Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript

Aug 16, 2023 / 04:00PM GMT
Release Date Price: $0.5255 (-1.87%)
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate

Welcome to our next fireside chat. I'm John Sourbeer, one of the UBS Life Sciences analyst. Joining me on stage is my co-coverage, Alysa Garcia. We're happy to host Singular Genomics here for our next fireside chat. With us today on stage is Drew Spaventa, Founder and CEO; and Dalen Meeter, who's Head of Finance. Thanks for joining us.

Questions & Answers

John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate

So maybe kick things off here. Let's start with the G4 launch. So you now have 11 commercial units in the field. Maybe you can provide some of the initial feedback from customers? Any learnings that you've now had over the last 3 quarters since the launch?

Andrew Spaventa
Singular Genomics Systems, Inc. - Founder, CEO, President & Chairperson of the Board

Yes, yes. And first of all, thanks for having us. It's good to be here. The G4 launch is underway at this point. Just to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot